Low risk of hepatitis B reactivation in patients with severe COVID‐19 who receive immunosuppressive therapy

A significant proportion of patients infected with SARS‐CoV‐2 develop severe respiratory symptoms due to an excessive immune response. Treatment of this condition may include immunosuppressive therapies, such as IL‐6 receptor antagonists and corticosteroids, which pose a risk for patients with activ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Viral Hepat
Hauptverfasser: Rodríguez‐Tajes, Sergio, Miralpeix, Anna, Costa, Josep, López‐Suñé, Ester, Laguno, Montserrat, Pocurull, Anna, Lens, Sabela, Mariño, Zoe, Forns, Xavier
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2020
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537127/
https://ncbi.nlm.nih.gov/pubmed/32969557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvh.13410
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge